![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2023/08/08/2720562/0/en/Sparian-Biosciences-Awarded-19-Million-Five-Year-NIH-NIDA-Grant-to-Fund-Development-of-SBS-518-for-Stimulant-Use-Disorder-Through-Phase-1-Clinical-Development.html